Aperio Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.11M | Sell |
6,639
-1,132
| -15% | -$189K | ﹤0.01% | 1543 |
|
|
2020
Q3 | $1.2M | Buy |
7,771
+256
| +3% | +$39.5K | ﹤0.01% | 1351 |
|
|
2020
Q2 | $1.11M | Buy |
7,515
+1,761
| +31% | +$260K | ﹤0.01% | 1365 |
|
|
2020
Q1 | $648K | Sell |
5,754
-698
| -11% | -$78.6K | ﹤0.01% | 1508 |
|
|
2019
Q4 | $898K | Buy |
6,452
+1,505
| +30% | +$209K | ﹤0.01% | 1488 |
|
|
2019
Q3 | $476K | Buy |
4,947
+365
| +8% | +$35.1K | ﹤0.01% | 1780 |
|
|
2019
Q2 | $528K | Buy |
4,582
+147
| +3% | +$16.9K | ﹤0.01% | 1760 |
|
|
2019
Q1 | $522K | Sell |
4,435
-1,712
| -28% | -$202K | ﹤0.01% | 1730 |
|
|
2018
Q4 | $385K | Sell |
6,147
-786
| -11% | -$49.2K | ﹤0.01% | 1837 |
|
|
2018
Q3 | $491K | Buy |
6,933
+431
| +7% | +$30.5K | ﹤0.01% | 1770 |
|
|
2018
Q2 | $433K | Sell |
6,502
-3,557
| -35% | -$237K | ﹤0.01% | 1814 |
|
|
2018
Q1 | $658K | Buy |
10,059
+3,191
| +46% | +$209K | ﹤0.01% | 1560 |
|
|
2017
Q4 | $275K | Buy |
6,868
+209
| +3% | +$8.37K | ﹤0.01% | 1990 |
|
|
2017
Q3 | $241K | Buy |
+6,659
| New | +$241K | ﹤0.01% | 2042 |
|
|
2017
Q2 | – | Sell |
-7,242
| Closed | -$203K | – | 2210 |
|
|
2017
Q1 | $203K | Buy |
+7,242
| New | +$203K | ﹤0.01% | 2032 |
|